ClinicalTrials.gov
public full text
Public Domain
Effect of Prebiotics on Hyperuricemia
Hyperuricemia is a major risk factor for many chronic diseases. Recently, dysbiosis of gut microbiota has been reported to play an important role in the pathogenesis of Hyperuricemia. Animal studies have demonstrated that administration of prebiotics help delay the progression of Hyperuricemia through several mechanisms. This trial aims to examine its protective effect in humans.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prebiotics and the Management of Hyperuricemia#1103704
- Probiotic Bacteria in Prevention of the Metabolic Syndrome#356567
- Taxonomic and functional remodeling of the gut microbiota during aging and implications for microbiota-derived biomarkers.#182406
- Microbiome-mediated regulation of pathogen virulence: Molecular mechanisms and clinical implications.#610280
- Long-term Effects of Arabinoxylans on Intestinal Barrier Function#889544
Record · ID 879589
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive